We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$1.18B
AUM Growth
+$135M
Cap. Flow
+$141M
Cap. Flow %
11.99%
Top 10 Hldgs %
28.51%
Holding
522
New
58
Increased
52
Reduced
58
Closed
93

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$33.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$32.7M
3
V icon
Visa
V
+$30.2M
4
EXEL icon
Exelixis
EXEL
+$21.2M
5
TT icon
Trane Technologies
TT
+$20.6M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$6.85M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$6.7M
3
ARW icon
Arrow Electronics
ARW
+$6.63M
4
YPF icon
YPF
YPF
+$6.31M
5
SNPS icon
Synopsys
SNPS
+$6.28M

Sector Composition

Rank Sector Weight
1 Technology 23.9%
2 Healthcare 21.38%
3 Financials 15.14%
4 Consumer Discretionary 14.1%
5 Industrials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THRM icon
426
Gentherm
THRM
$1.25B
$878 ﹤0.01%
22
– –
SEM
427
DELISTED
Select Medical
SEM
$660 ﹤0.01%
35
-7,640
-100% -$147K
VC icon
428
Visteon
VC
$2.79B
$621 ﹤0.01%
7
– –
OPCH icon
429
Option Care Health
OPCH
$3.45B
$603 ﹤0.01%
26
– –
ACN icon
430
Accenture
ACN
$102B
– –
-37
Closed -$13.1K
AEO icon
431
American Eagle Outfitters
AEO
$2.88B
– –
-61
Closed -$1.37K
ALTO icon
432
Alto Ingredients
ALTO
$369M
– –
-72,618
Closed -$117K
AMN icon
433
AMN Healthcare
AMN
$1.3B
– –
-65
Closed -$2.75K
AMPH icon
434
Amphastar Pharmaceuticals
AMPH
$879M
– –
-1,210
Closed -$58.7K
ANET icon
435
Arista Networks
ANET
$227B
– –
-160
Closed -$15.4K
AVNW icon
436
Aviat Networks
AVNW
$265M
– –
-66,478
Closed -$1.44M
BAX icon
437
Baxter International
BAX
$13.5B
– –
-3,800
Closed -$144K
BFAM icon
438
Bright Horizons
BFAM
$3.92B
– –
-46
Closed -$6.45K
BKNG icon
439
Booking.com
BKNG
$149B
– –
-925
Closed -$156K
BURL icon
440
Burlington
BURL
$23.2B
– –
-1,000
Closed -$263K
C icon
441
Citigroup
C
$222B
– –
-168
Closed -$10.5K
CAL icon
442
Caleres
CAL
$431M
– –
-2,099
Closed -$69.4K
CASY icon
443
Casey's General Stores
CASY
$32.2B
– –
-472
Closed -$177K
CCEP icon
444
Coca-Cola Europacific Partners
CCEP
$48.3B
– –
-85,085
Closed -$6.7M
CCS icon
445
Century Communities
CCS
$1.91B
– –
-1,080
Closed -$111K
CSL icon
446
Carlisle Companies
CSL
$14.3B
– –
-3,500
Closed -$1.57M
DKS icon
447
Dick's Sporting Goods
DKS
$17.5B
– –
-470
Closed -$98.1K
EG icon
448
Everest Group
EG
$14.5B
– –
-4,307
Closed -$1.69M
EL icon
449
Estee Lauder
EL
$30.4B
– –
-13
Closed -$1.3K
ELS icon
450
Equity Lifestyle Properties
ELS
$12.6B
– –
-123
Closed -$8.78K
16 17
18
19 20

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Globeflex Capital held 522 positions worth $1.18B, up 13% from $1.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Globeflex Capital deployed $141M of net new capital in Q4 2024, opening 58 new positions and adding to 52 existing holdings. Its largest new stake was Bristol-Myers Squibb: 602,224 shares worth $34.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arrow Electronics, an estimated $6.63M trimmed.

  • Globeflex Capital's largest Q4 2024 buy was Bristol-Myers Squibb: 602,224 shares worth $34.1M.
  • Globeflex Capital added most to Alphabet (Google) Class C in Q4 2024, an estimated $32.7M increase.
  • Globeflex Capital's biggest Q4 2024 reduction was Arrow Electronics, cutting an estimated $6.63M.
  • Globeflex Capital fully exited Hologic in Q4 2024, selling an estimated $6.85M.
  • Globeflex Capital's ten largest holdings make up 29% of its $1.18B portfolio in Q4 2024.
  • Globeflex Capital opened 58 new positions and closed 93 in Q4 2024.
  • Globeflex Capital's portfolio value rose 13% quarter-over-quarter to $1.18B.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.